bromocriptine has been researched along with amantadine in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 60 (56.07) | 18.7374 |
1990's | 21 (19.63) | 18.2507 |
2000's | 15 (14.02) | 29.6817 |
2010's | 10 (9.35) | 24.3611 |
2020's | 1 (0.93) | 2.80 |
Authors | Studies |
---|---|
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Winkelman, AC | 1 |
Hungerbühler, JP; Regli, F | 1 |
Pöldinger, W | 1 |
Przuntek, H | 1 |
Hill, JW | 1 |
Durand, JP; Gautier, JC | 1 |
Agnoli, A; Casacchia, M; Ruggieri, S | 1 |
Parkes, D | 1 |
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Camanni, F; Isaia, GC; Massara, F; Molinatti, GM | 1 |
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
Suitsu, N | 1 |
Morgan, MY | 1 |
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F | 1 |
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY | 1 |
Borzecki, Z; Kaliszuk, S; Swies, Z | 1 |
Nakashima, K; Takahashi, K | 1 |
Onodera, K; Shinoda, H | 1 |
Jacobs, MB; Varon, J | 1 |
Gold, MS; Taylor, WA | 1 |
Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V | 1 |
Bar, M; Graff, E; Isakov, M; Oberman, Z; Rabey, JM; Scharf, M | 1 |
Hippius, H; Spiess-Kiefer, C | 1 |
Geber, J; Gjuris, V; Jagić, V; Krizanac, S; Mise, S; Petek, M; Rotkvić, I; Sikirić, P; Suchanek, E; Udovicić, I | 1 |
Feather, JN; Folts, DJ; Giannini, AJ; Sullivan, BS | 1 |
Lazarus, A | 3 |
Harvey, NS | 1 |
Munitz, H; Shalev, A | 1 |
Huber, M | 1 |
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
Aminoff, MJ | 1 |
Gawin, F; Kleber, H; Kosten, T; Morgan, C | 1 |
Guerrero, RM; Shifrar, KA | 1 |
Berman, ML; Tennant, F | 1 |
Abbott, RJ; Loizou, LA | 1 |
Sagherian, AA; Tennant, FS | 1 |
Lakke, JP; Staal-Schreinemachers, AL | 1 |
Muenter, MD | 2 |
Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H | 1 |
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
Baxter, LR; Guzé, BH | 1 |
Wirz, D | 1 |
Addonizio, G; Susman, VL | 1 |
Ciolino, C; Rosse, R | 1 |
Grau-Veciana, JM; Peiró Grasa, A | 1 |
Larsen, TA; Teräväinen, H | 1 |
Weiner, M | 1 |
Tegeler, J; Wöller, W | 1 |
West, AP | 1 |
Neppe, VM | 1 |
Jörg, J | 1 |
Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
Alonso, RJ; Covington, TR; Mancall, EL | 1 |
Morris, JG | 2 |
Mattila, MJ; Nuotto, E | 1 |
Fincke, M; Gothóni, P; Lehtinen, M | 1 |
Veje, JO | 1 |
Goetz, CG; Nausieda, PA; Tanner, CM | 1 |
Boismare, F; Leclerc, JL; Moore, N; Saligaut, C | 1 |
Stewart, RM | 1 |
Danielczyk, W | 1 |
Boada, JN; Feria, M; Padron, F | 1 |
Bertha, G; Lechner, H; Ott, E | 1 |
Janjua, R; Roos, RA; van Kempen, GM | 1 |
Danysz, W; Quack, G; Rogoz, Z; Skuza, G | 1 |
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O | 1 |
Marken, PA; Schneiderhan, ME | 1 |
Kornhuber, J; Weller, M | 1 |
Kishore, A; Snow, BJ | 1 |
Kuno, S | 1 |
Geyer, MA; Oostwegel, JL; Randolph, E; Swerdlow, NR; Taaid, N | 1 |
Burke, DT; Calvanio, R; Fitzpatrick, M; Karli, DC; Kim, HJ; Lepak, P; Macneil, M; Pesez, K; Temple, D | 1 |
Sunohara, N | 1 |
Farrell, M; Lima, MS; Reisser, AA; Soares, BG | 2 |
Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR | 1 |
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U | 1 |
Auerbach, PP; Ross, L; Shoemaker, JM; Stephany, N; Swerdlow, NR; Talledo, J; Wasserman, LC | 1 |
Reingardiene, D | 1 |
Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD | 1 |
Okamoto, K; Tanaka, M | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Elovic, EP; Napolitano, E; Qureshi, AI | 1 |
Caroff, SN; Keck, PE; Strawn, JR | 1 |
Farrell, M; Lima Reisser, AA; Silva de Lima, M; Soares, B | 1 |
Aubut, JA; Bayley, M; Foley, N; Marshall, S; Megyesi, J; Meyer, MJ; Meythaler, J; Murie-Fernandez, M; Salter, K; Teasell, R | 1 |
Duggan, C; Ferriter, M; Huband, N; Khalifa, N; Lieb, K; Stoffers, J; Völlm, BA | 1 |
Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F | 1 |
Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
Majid, H; Zubair, UB | 1 |
Cheung, NH; Gibbon, S; Khalifa, NR; McCarthy, L; Völlm, BA | 1 |
31 review(s) available for bromocriptine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
Drug therapy: Bromocriptine.
Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
The treatment of chronic hepatic encephalopathy.
Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A | 1991 |
Pharmacologic approaches to the treatment of cocaine dependence.
Topics: Amantadine; Antidepressive Agents, Tricyclic; Bromocriptine; Cocaine; Dopamine Agents; Humans; Substance-Related Disorders | 1990 |
Neuroleptic malignant syndrome.
Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis | 1989 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
[Parkinson disease. The clinical picture and therapy].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease | 1988 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats | 1986 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics | 1985 |
Update on the treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors | 1985 |
Update on antiparkinsonian agents.
Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance | 1982 |
The management of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease | 1982 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl | 1996 |
[Treatment of Parkinson's disease with multiple drugs].
Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders | 1999 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
Dopamine agonists for cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine; Humans; Randomized Controlled Trials as Topic | 2001 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
Dopamine agonists for cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine Agonists; Humans; Randomized Controlled Trials as Topic | 2003 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.
Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate | 2005 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors | 2007 |
WITHDRAWN: Dopamine agonists for cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Dopamine Agonists; Humans; Randomized Controlled Trials as Topic | 2010 |
Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma.
Topics: Amantadine; Arousal; Brain Injuries; Bromocriptine; Coma, Post-Head Injury; Dopamine Agonists; Evidence-Based Medicine; Humans; Levodopa; Music Therapy; Randomized Controlled Trials as Topic; Recovery of Function | 2010 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Nortriptyline; Phenytoin; Psychotropic Drugs; Randomized Controlled Trials as Topic | 2010 |
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic | 2011 |
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias | 2015 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Middle Aged; Nortriptyline; Phenytoin; Placebos; Psychotropic Drugs; Randomized Controlled Trials as Topic | 2020 |
10 trial(s) available for bromocriptine and amantadine
Article | Year |
---|---|
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oxprenolol; Tremor | 1978 |
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary | 1977 |
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1978 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl | 1992 |
Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.
Topics: Adult; Aged; Amantadine; Bromocriptine; Cimetidine; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Recurrence | 1991 |
Bromocriptine and amantadine in cocaine detoxification.
Topics: Adult; Amantadine; Brain; Bromocriptine; Clinical Trials as Topic; Cocaine; Humans; Male; Random Allocation; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence.
Topics: Adult; Amantadine; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome | 1988 |
Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
Topics: Adolescent; Adult; Amantadine; Ambulatory Care; Bromocriptine; Clinical Trials as Topic; Cocaine; Double-Blind Method; Humans; Patient Compliance; Substance Withdrawal Syndrome | 1987 |
Weekly drug holiday in Parkinson disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
66 other study(ies) available for bromocriptine and amantadine
Article | Year |
---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Update on drug treatment of Parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1977 |
Drugs for Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines | 1978 |
In practice. Parkinson's disease.
Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission | 1979 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1979 |
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia | 1991 |
Drug treatment of the neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome | 1991 |
The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
Topics: Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Male; Metoclopramide; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sulpiride | 1990 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Treating the progressive stages of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline | 1991 |
Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease.
Topics: Administration, Oral; Aged; Amantadine; Biperiden; Bromocriptine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Piperidines | 1990 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk | 1986 |
The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats.
Topics: Acute Disease; Amantadine; Amylases; Animals; Bromocriptine; Domperidone; Female; Male; Pancreas; Pancreatitis; Rats; Rats, Inbred F344; Receptors, Dopamine | 1988 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Parkinson's disease in the elderly: current management strategies.
Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1987 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1988 |
Diagnosis and treatment of neuroleptic malignant syndrome.
Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome | 1988 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
[Antiparkinson agents].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Lisuride; Parasympatholytics | 1987 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Pharmacotherapy: problems and practices.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
Drugs for parkinsonism.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
[Revision of the treatment strategy in Parkinson disease].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning | 1986 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Assessing treatment of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Cortisone; Drug Therapy, Combination; Humans; Neuroleptic Malignant Syndrome; Piperidines | 1986 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1985 |
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1985 |
[Drug therapy of parkinsonism].
Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease | 1982 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid | 1983 |
Treatments for neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male | 1984 |
The neuroleptic malignant syndrome. A priority system.
Topics: Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Consciousness Disorders; Dantrolene; Fever; Humans; Muscle Rigidity; Phenytoin; Syndrome | 1984 |
Treating neuroleptic malignant syndrome.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Muscle Rigidity | 1984 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor | 1983 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease | 1984 |
Failure of amantadine and bromocriptine to counteract alcoholic inebriation in man.
Topics: Adult; Alcoholic Intoxication; Amantadine; Bromocriptine; Double-Blind Method; Humans; Kinetics; Male; Prolactin; Psychomotor Performance | 1984 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
[Drug information: antiparkinson agents III. Amantadine (Symmetrel), bromocriptine (Parlodel)].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine | 1981 |
Initial treatment of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis | 1982 |
Dopaminergic agonists and conditioned avoidance response in normoxic or hypoxic rats.
Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Bromocriptine; Dopamine; Female; Hypoxia; Piribedil; Rats | 1981 |
Parkinson's disease: new treatments.
Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus | 1981 |
[Crises in the course of Parkinson's disease].
Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders | 1980 |
Respiratory effects of amantadine and bromocriptine and their interaction with haloperidol in anesthetized rats.
Topics: Amantadine; Anesthesia; Animals; Bromocriptine; Drug Interactions; Haloperidol; Male; Rats; Respiration; Time Factors | 1980 |
[Current treatment of Parkinsonian syndrome].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease, Secondary | 1980 |
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome | 1995 |
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 1994 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine | 1994 |
An atypical course of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors | 1994 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats.
Topics: Acoustic Stimulation; Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Interactions; Humans; Indoles; Male; Pergolide; Rats; Rats, Sprague-Dawley; Reflex, Startle; Species Specificity | 1998 |
Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation.
Topics: Accidental Falls; Adult; Akathisia, Drug-Induced; Amantadine; Brain Injuries; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Frontal Lobe; Hallucinations; Humans | 1999 |
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors | 2002 |
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema | 2002 |
Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons.
Topics: Acoustic Stimulation; Adult; Amantadine; Analysis of Variance; Animals; Bromocriptine; Dose-Response Relationship, Drug; Humans; Male; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reflex, Startle; Species Specificity | 2002 |
The use of dopamine enhancing medications with children in low response states following brain injury.
Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness | 2003 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl | 2003 |
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
Anti-NMDA Receptor Encephalitis in a Young Girl with Altered Behaviour and Abnormal Movements.
Topics: Adolescent; Amantadine; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Bromocriptine; Dyskinesias; Female; Humans; Leukocytosis; Methylprednisolone; Nervous System Diseases; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2018 |